Compare Enphase Energy Inc (ENPH) vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enphase Energy Inc vs Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) — how do they compare? Enphase Energy Inc trades at $33.24 (market cap $4.43B), while Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) trades at $18.35 (market cap $58.16B). The key difference: Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) is far larger — about 13.1× Enphase Energy Inc's market cap, and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) pays a 3.36% dividend while Enphase Energy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Enphase Energy Inc for 72 Days and Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) for 0 Days on average.
| ENPH | TAK | |
|---|---|---|
Market Cap | $4.43B | $58.16B |
Volume | 3,388,482 | 2,467,530 |
Sector | Energy | Health |
52-Week High | $72.33 | $19.05 |
52-Week Low | $26.12 | $13.23 |
Typical Hold Time | 72 Days | 0 Days |
Enterprise Value | $4.07B | $86.04B |
Dividend Yield | — | 3.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Enphase Energy (ENPH) trades at $32.91, down 2.95% on the day, amid a bearish technical signal and mixed earnings history. The stock shows weakening revenue and net income from 2023 peaks, with 2025 revenue at $1.47B and net income of $172.13M. Recent news highlights volatility in solar stocks due to high borrowing costs, though Enphase advances with IQ Meter Collar approvals and solid-state transformer development for AI data centers.
Outlook is cautious; while analyst consensus targets $42.90 (30% upside), recent earnings misses and bearish technicals suggest near-term pressure. Risks include solar industry headwinds and execution challenges, but long-term growth potential exists in energy technology expansion. Investors should weigh valuation metrics like P/E of 33.17 against competitive and macroeconomic risks.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Enphase Energy Inc
Enphase Energy is a global energy technology company. The company delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Geographically, it derives a majority of revenue from the United States.
Read more on ENPH →About Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)
Takeda is a Japanese pharmaceutical company developing medicines across areas including gastrointestinal disease, rare diseases, neuroscience, oncology, and plasma-derived therapies.
Read more on TAK →
